Selected article for: "CTL epitope and proteasomal cleavage"

Author: Srivastava, Sukrit; Kamthania, Mohit; Singh, Soni; Saxena, Ajay K; Sharma, Nishi
Title: Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach
  • Document date: 2018_11_21
  • ID: 33h22ikl_8
    Snippet: To screen CTL epitopes, the Immune Epitope Database (IEDB) tool "Proteasomal cleavage/TAP transport/MHC class I combined predictor" (http://tools.iedb.org/processing/) was used. [23] [24] [25] The total score generated by the tool is a combined score of proteasome, TAP (N-terminal interaction), major histocompatibility complex (MHC), and processing analysis scores. The score is generated using the combination of six methods, namely, Consensus, NN.....
    Document: To screen CTL epitopes, the Immune Epitope Database (IEDB) tool "Proteasomal cleavage/TAP transport/MHC class I combined predictor" (http://tools.iedb.org/processing/) was used. [23] [24] [25] The total score generated by the tool is a combined score of proteasome, TAP (N-terminal interaction), major histocompatibility complex (MHC), and processing analysis scores. The score is generated using the combination of six methods, namely, Consensus, NN-align, SMM-align, Combinatorial Library, Sturniolo, and NetMHCIIpan. The IC50 (nM) value was also obtained using this IEDB tool. Epitopes with high, intermediate, and least affinity of binding to an HLA allele have IC50 values <50 nM, <500 nM, and <5,000 nM, respectively. Immunogenicity of the screened CTL epitopes was also obtained by the "MHC I Immunogenicity" tool of IEDB (http://tools.iedb.org/ immunogenicity/) with all parameters set to default (first, second, and C-terminus amino acids). 26 The tool predicts immunogenicity of a peptide MHC complex on the basis of physiochemical properties of amino acids and their position within the short peptide sequence.

    Search related documents:
    Co phrase search for related documents
    • amino acid and combined score: 1, 2
    • amino acid and CTL epitope: 1, 2, 3, 4, 5, 6, 7
    • amino acid and histocompatibility complex: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • amino acid and HLA bind: 1, 2, 3
    • amino acid and IEDB Immunogenicity tool: 1
    • amino acid and IEDB tool: 1, 2
    • amino acid and Immunogenicity tool: 1, 2
    • amino acid and major histocompatibility complex: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • amino acid and MHC class: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • amino acid and MHC complex: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • analysis score and combined score: 1, 2, 3, 4
    • analysis score and IEDB tool: 1, 2
    • combined score and histocompatibility complex: 1, 2, 3
    • combined score and IEDB tool: 1
    • combined score and major histocompatibility complex: 1, 2, 3
    • combined score and MHC class: 1, 2, 3
    • CTL epitope and IEDB tool: 1
    • CTL epitope and major histocompatibility complex: 1, 2, 3, 4, 5, 6
    • CTL epitope and MHC class: 1, 2, 3, 4, 5, 6